Ontology highlight
ABSTRACT: Background
Bronchoscopic lung volume reduction (BLVR) using 1-way endobronchial valves (EBV) has become a guideline treatment in patients with advanced emphysema. Evidence from this minimally invasive treatment derives mainly from well-designed controlled trials conducted in high-volume specialized intervention centres. Little is known about real-life outcome data in hospitals setting up this novel treatment and which favourable conditions are required for a continuous successful program.Objectives
In this study, we aim to evaluate the eligibility rate for BLVR and whether the implementation of BLVR in our academic hospital is feasible and yields clinically significant outcomes.Method
A retrospective evaluation of patients treated with EBV between January 2016 and A
SUBMITTER: Posthuma R
PROVIDER: S-EPMC9153356 | biostudies-literature | 2022
REPOSITORIES: biostudies-literature